Fri, February 16, 2024
Thu, February 15, 2024
Wed, February 14, 2024

Rachel Vatnsdal Maintained (ADPT) at Buy with Decreased Target to $8 on, Feb 15th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-feb-15th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Rachel Vatnsdal of JP Morgan, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $11 to $8 on, Feb 15th, 2024.

Rachel has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Rachel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $10 on, Tuesday, October 24th, 2023


This is the rating of the analyst that currently disagrees with Rachel


  • David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $6 on, Monday, November 13th, 2023

Publication Contributing Sources